Aspiriant LLC’s iShares Core 1-5 Year USD Bond ETF ISTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,015
Closed -$711K 297
2024
Q2
$711K Hold
15,015
0.03% 170
2024
Q1
$712K Sell
15,015
-2,561
-15% -$121K 0.03% 165
2023
Q4
$836K Sell
17,576
-412
-2% -$19.2K 0.04% 154
2023
Q3
$834K Sell
17,988
-826
-4% -$38.4K 0.04% 150
2023
Q2
$877K Hold
18,814
0.04% 145
2023
Q1
$887K Sell
18,814
-809
-4% -$37.9K 0.05% 139
2022
Q4
$911K Buy
+19,623
New +$908K 0.05% 137

Other funds holding ISTB

Aspiriant LLC's ISTB Position: Q3 2024 in Review

Aspiriant LLC sold out of iShares Core 1-5 Year USD Bond ETF (ISTB) in Q3 2024, closing a stake of 15,015 shares — an estimated $711K sold.

Aspiriant LLC first reported a position in ISTB in Q4 2022 and held it in 7 quarters. The position peaked at $911K in Q4 2022. 359 funds tracked by Wall St. Rank hold ISTB as of Q3 2024.

  • Aspiriant LLC reported no remaining iShares Core 1-5 Year USD Bond ETF position as of Q3 2024 after selling out during the quarter.
  • Aspiriant LLC sold 15,015 iShares Core 1-5 Year USD Bond ETF shares in Q3 2024, an estimated $711K.
  • Aspiriant LLC first reported a position in iShares Core 1-5 Year USD Bond ETF in Q4 2022 and held it in 7 quarters.
  • Aspiriant LLC's iShares Core 1-5 Year USD Bond ETF position peaked at $911K in Q4 2022.
  • 359 funds tracked by Wall St. Rank held iShares Core 1-5 Year USD Bond ETF as of Q3 2024.

Based on Aspiriant LLC's 13F filing for Q3 2024, filed 17 Oct 2024.